Chloroprocaine for Continuous Epidural Analgesia in Neonates and Infants

Completed

• Conditions: Anesthesia
• Interventions: Drug: Chloroprocaine

• Registration Number: NCT02207855
• Lead Sponsor: Joseph D. Tobias

Brief Summary

This a study to retrospectively review our experience with the use of chloroprocaine for postoperative epidural infusions in neonates and infants. Pain scores and the need for intravenous analgesic agents will be recorded from the records to demonstrate the efficacy of the technique.

Detailed Description

Not available

Study Timeline

• Study Start: 2014-06
• Study First Submitted: 2014-08-01
• Study First Submitted QC: 2014-08-01
• Study First Posted: 2014-08-04
• Primary Completion: 2015-03
• Study Completion: 2015-03
• Status Verified: 2016-11
• Last Update Submitted: 2016-11-28
• Last Update Posted: 2016-11-29

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 21

Inclusion Criteria

• Neonates and infants who have received chloroprocaine for epidural anesthesia.

Exclusion Criteria

• None

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
Chloroprocaine	Chloroprocaine	Neonates and infants who have received chloroprocaine for epidural anesthesia.

Primary Outcome Measures

Name	Time	Method
Pain score	Every 6 hours for 72 hours

Secondary Outcome Measures

Name	Time	Method
Pain medicine consumption	Every 6 hours for 72 hours

Trial Locations

Locations (1)

Nationwide Children's Hospital; 🇺🇸 Columbus, Ohio, United States